Navigation Links
Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009
Date:3/12/2009

Gallios(TM) Flow Cytometry System Offers New Standard of Performance for Researchers

ORANGE COUNTY, Calif., March 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, and manufacturer of products that simplify and automate complex biomedical testing, announced today that it has launched the Gallios Flow Cytometer, the first of several instrument, software and reagent introductions in the year for both clinical and research applications in flow cytometry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

The new Gallios Flow Cytometer, targeted to the research market, delivers analytical excellence combined with high speed data collection. Features - including advanced optics, patented electronics design, and novel software tools - improve lab workflow and quality control, delivering increased sensitivity and resolution in less time and at higher speeds. Researchers can readily see small and subtle changes in cell populations, and the system accelerates data generation.

"Every aspect of the Gallios design increases application performance. When combined with our broad and high quality reagent portfolio, we provide a new and powerful solution for cellular analysis, increasing productivity and improving the reliability and reproducibility of results," said Cynthia Collins, group vice president of Cellular Analysis at Beckman Coulter.

The analyzer's efficient, compact design allows laboratories to maximize valuable space. The system comes in three scaleable configurations that allow for future addition of more lasers and fluorescence detectors as the need for complex multi-color flow cytometry expands.

Collins added, "We are adding a number of exciting products to our flow cytometry portfolio this year. They are a testament to our commitment to enhancing the efficiency of flow cytometry laboratories around the globe."

About Beckman Coulter

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

    Contacts:  Mary Luthy, Beckman Coulter   Cynthia Skoglund, Beckman Coulter
               Corporate Communications      Investor Relations
               (714) 773-7964                (714) 773-7620


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Beckman Coulter to Present at Upcoming Healthcare Conferences
2. Beckman Coulter Announces Third Quarter 2008 Results
3. Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens
5. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
6. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
7. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
8. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
9. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
10. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
11. Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: